GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Common Stock

Neurotech International (ASX:NTI) Common Stock : A$46.74 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Common Stock?

Neurotech International's quarterly common stock increased from Jun. 2023 (A$34.35 Mil) to Dec. 2023 (A$35.80 Mil) and increased from Dec. 2023 (A$35.80 Mil) to Jun. 2024 (A$46.74 Mil).

Neurotech International's annual common stock increased from Jun. 2022 (A$25.78 Mil) to Jun. 2023 (A$34.35 Mil) and increased from Jun. 2023 (A$34.35 Mil) to Jun. 2024 (A$46.74 Mil).


Neurotech International Common Stock Historical Data

The historical data trend for Neurotech International's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Common Stock Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Common Stock
Get a 7-Day Free Trial 15.50 25.75 25.78 34.35 46.74

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.78 34.59 34.35 35.80 46.74

Neurotech International Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Neurotech International Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company conducting clinical studies to assess the neuroprotective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. Geographically, all the firm's business activities function through the region of Australia. It operates in one segment: Medical Device Development and Distribution.

Neurotech International Headlines

From GuruFocus

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013